期刊文献+

ICBP90介导PI3K/AKT通路阻断剂LY294002抑制Jurkat T细胞增殖 被引量:1

Inhibitor LY294002 of PI3K/AKT signal pathway mediated by ICBP90 inhibits proliferation of Jurkat T cell
下载PDF
导出
摘要 目的:探讨磷脂酰肌醇3激酶/丝氨酸苏氨酸蛋白激酶B(PI3K/AKT)信号通路特异性抑制剂LY294002在Jurkat T细胞增殖中的作用。方法:以急性T细胞白血病细胞(Jurkat T细胞)为模型,PD98059和阿霉素为阳性对照,在倒置显微镜下观察LY294002对Jurkat T细胞的集落形成的影响,四甲基偶氮唑蓝(MTT)检测LY294002处理后Jurkat T细胞的增殖,流式细胞术检测LY294002处理后Jurkat T细胞周期的变化,Western blotting方法检测Jurkat T细胞中ICBP90蛋白的表达以确定其与LY294002抑制Jurkat T细胞增殖的关系。结果:LY294002能够显著抑制Jurkat T细胞的集落形成和增殖,使Jurkat T细胞停滞于G2/M期,导致Jurkat T细胞ICBP90蛋白的表达显著降低,LY294002与阿霉素联合用药可产生一定的协同效应。结论:LY294002通过下调Jur-kat T细胞ICBP90蛋白的表达,抑制Jurkat T细胞增殖。 Aim:To investigate the role of LY294002 which is the inhibitor of PI3K/Akt signal pathway in proliferation of Jurkat T and expression level of ICBP90. Methods: Jurkat T cells were used as a suitable model for this study.The positive control was Adriamycin and PD98059.Inverted microscope was used to observe the colony formation of Jurkat T cells.The proliferation of cells treated by LY294002,PD98059,Adriamycin,LY294002 combining with Adriamycin and PD98059 combining with Adriamycin,respectively,was checked by MTT method.The effect of these drugs on the cell cycle distribution of Jurkat T cells was analyzed by flow cytometry.Western blotting was used to determine the level of ICBP90 expression in Jurkat T cells treated by the drugs.Results: The proliferation of Jurkat T cells was inhibited by LY294002.LY294002 can make Jurkat T cell arrest at G2/M phase.The expression of ICBP90 declined in the group added LY294002.LY294002 combining with Adriamycin exerted the synergetic role to some extent.Conclusion:LY294002 can down-regulate expression of ICBP90 and inhibit Jurkat T cell proliferation,indicating that ICBP90 might mediate LY294002 to inhibit Jurkat T cell proliferation.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2009年第4期361-366,共6页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家自然科学基金资助项目(30471635) 广东省自然科学基金资助项目(04010451 5006033)
  • 相关文献

参考文献2

二级参考文献13

  • 1Tan J,Hallahan DE.Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response.Cancer Res,2003,63:7663-7667.
  • 2Brognard J,Clark AS,Ni Y,et al.Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.Cancer Res,2001,61:3986-3997.
  • 3周廷潮,韩锐,胥彬.多种药物协同及拮抗作用地定量分析原理在化疗中的应用.见:韩锐,主编.肿瘤化学预防及药物治疗.北京:北京医科大学中国协和医科大学联合出版社,1991,315-320.
  • 4Gupta AK,Bakanauskas VJ,Cerniglia GJ,et al.The Ras radiation resistance pathway.Cancer Res,2001,61:4278-4282.
  • 5Dicuonzo G,Angeletti S,Garcia-Foncillas J,et al.Colorectal carcinomas and PTEN/MMAC1 gene mutations.Clin Cancer Res,2001,7:4049-4053.
  • 6Tanabe K,Kim R,Inoue H,et al.Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.Int J Oncol,2003,22:875-881.
  • 7Fraser M,Brendan M,Yan XJ,et al.p53 is a Determinant of XLinked Inhibitor of Apoptosis Protein/Akt-Mediated Chemoresistance in Human Ovarian Cancer Cells.Cancer Res,2003,63:7081-7088.
  • 8Gupta AK,Cerniglia GJ,Mick R,et al.Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.Int J Radiat Oncol Biol Phys,2003,56:846-853.
  • 9Brognard J,Clark AS,Ni Y,et al.Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.Cancer Res,2001,61:3986-3997.
  • 10Chakravarti A,Chakladar A,Delaney MA,et al.The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.Cancer Res,2002,62:4307-4315.

共引文献87

同被引文献11

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部